Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013

Hanevik, 2014, Irritable bowel syndrome and chronic fatigue 6 years after Giardia infection: a controlled prospective cohort study, Clin Infect Dis, 59, 1394, 10.1093/cid/ciu629 Escobedo, 2007, Giardiasis: a pharmacotherapy review, Expert Opin Pharmacother, 8, 1885, 10.1517/14656566.8.12.1885 Lopez-Velez, 2010, Short course combination therapy for giardiasis after nitroimidazole failure, Am J Trop Med Hyg, 83, 171, 10.4269/ajtmh.2010.09-0742 Muñoz Gutiérrez, 2013, Refractory giardiasis in Spanish travellers, Travel Med Infect Dis, 11, 126, 10.1016/j.tmaid.2012.10.004 Robertson, 2010, Giardiasis—why do the symptoms sometimes never stop?, Trends Parasitol, 26, 75, 10.1016/j.pt.2009.11.010 Nash, 2001, Treatment of patients with refractory giardiasis, Clin Infect Dis, 33, 22, 10.1086/320886 Watkins, 2014, Treatment of giardiasis: current status and future directions, Curr Infect Dis Rep, 16, 396, 10.1007/s11908-014-0396-y Cacopardo, 1995, Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis, Clin Ter, 146, 761 Mørch, 2008, Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway, J Infect, 56, 268 Boreham, 1988, Altered uptake of metronidazole in vitro by stocks of Giardia intestinalis with different drug sensitivities, Trans R Soc Trop Med Hyg, 82, 104, 10.1016/0035-9203(88)90278-7 Upcroft, 1993, Drug resistance and Giardia, Parasitol Today, 9, 187, 10.1016/0169-4758(93)90144-5 Pal, 2009, Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases), Antimicrob Agents Chemother, 53, 458, 10.1128/AAC.00909-08 Tejman-Yarden, 2011, Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia, Antimicrob Agents Chemother, 55, 4643, 10.1128/AAC.00384-11 Müller, 2007, Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole, J Antimicrob Chemother, 60, 280, 10.1093/jac/dkm205 Cruz, 2003, Isolation, excystation and axenization of Giardia lamblia isolates: in vitro susceptibility to metronidazole and albendazole, J Antimicrob Chemother, 51, 1017, 10.1093/jac/dkg150 Aurrecoechea, 2009, GiardiaDB and TrichDB: integrated genomic resources for the eukaryotic protist pathogens Giardia lamblia and Trichomonas vaginalis, Nucleic Acids Res, 37, D526, 10.1093/nar/gkn631 Bachmann, 2011, Trichomonas vaginalis genital infections: Progress and challenges, Clin Infect Dis, 53, 160, 10.1093/cid/cir705 Pandya, 2014, Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat, Indian J Med Microbiol, 32, 408, 10.4103/0255-0857.142256 Ganguly, 2011, Rationalizing antibiotic use to limit antibiotic resistance in India, Indian J Med Res, 134, 281 Ganguly, 2011 Radyowijati, 2003, Improving antibiotic use in low-income countries: an overview of evidence on determinants, Soc Sci Med, 57, 733, 10.1016/S0277-9536(02)00422-7 Rayasam, 2013, The irrational fixed dose combinations in the Indian drug market: an evaluation of prescribing pattern using WHO guidelines, Int J Basic Clin Pharmacol, 2, 452, 10.5455/2319-2003.ijbcp20130820 Gaskill, 1947, Toxic psychoses following Atabrine, Bull US Army Med Department, 86, 63 Awasthi, 1997, Prevalence of malnutrition and intestinal parasites in preschool slum children in Lucknow, Indian Pediatr, 34, 599 Halliez, 2013, Extra-intestinal and long term consequences of Giardia duodenalis infections, World J Gastroenterol, 19, 8974, 10.3748/wjg.v19.i47.8974 TropNet. GiardiaRef. http://www.tropnet.eu/index.php?id=197. Cañete, 2010, A randomized, controlled, open-label trial evaluating the efficacy and safety of chloroquine in the treatment of giardiasis in children, West Indian Med J, 59, 607